로딩 중…
지수 로딩 중…
Aura Biosciences, Inc.
AURA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$6.32+0.08%
2026-06-18
Price Chart
Aura Biosciences, Inc.+3.52%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $653M |
| Revenue | $0.00 |
| Net Income | $-112M |
| Total Assets | $138M |
| Net Assets | $107M |
| Value | |
| P/B | 6.09x |
| FCF Yield | -14.04% |
| Profitability | |
| ROE | -104.80% |
| ROA | -81.64% |
| Financial Health | |
| Debt Ratio | 28.37% |
| Total Debt | $17M |
| FCF | $-92M |
| Cash | $85M |
| Current Ratio | 7.09x |
| Performance | |
| 1Y Return | 3.52% |
| 1M Return | -14.55% |
| From 52W High | -33.80% |
| 1Y MDD | -31.26% |
| Trading | |
| Volume | 1,251,465 shares |
| Trading Value | $8M |
| Per Share | |
| EPS | $-1.22 |
| BPS | $2.38 |